Laboratory and clinical study with a new progestagen combined with ethinyl estradiol used in contraception
Galán, G.; Gayán, P.; Tisné, L.
Revista Chilena de Obstetricia y Ginecologia 50(4): 317-324
1985
ISSN/ISBN: 0048-766X PMID: 2953049 Document Number: 245323
Document emailed within 1 workday
Related Documents
Galán, G.; Gayán, P.; Tisné, L. 1985: Laboratory and clinical study with a new progestagen combined with ethinyl estradiol used in contraception Revista Chilena de Obstetricia y Ginecologia 50(4): 317-324Murray, E.; Bosch, L.R.; Lema, B.E. 1970: Clinical research on a new progestagen (norgestrel) combined with ethinyl estradiol Prensa Medica Argentina 57(31): 1485-1494
Krishnan, S.; Kiley, J. 2010: The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg International Journal of Women's Health 2: 235-239
Skouby, S.O. 1987: Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study International Journal of Fertility 32 Suppl: 45-48
Gaussem, P.; Alhenc-Gelas, M.; Thomas, J.-L.; Bachelot-Loza, C.; Remones, V.; Ali, F.D.; Aiach, M.; Scarabin, P.-Y. 2011: Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. a double-blind, randomised study Thrombosis and Haemostasis 105(3): 560-567
Oner, G.; Muderris, I.I. 2011: A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism Contraception 84(5): 508-511
Akerlund, M. 1997: Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol Acta Obstetricia et Gynecologica Scandinavica. Suppl 164: 63-65
Kashanian, M.; Shahpourian, F.; Zare, O. 2010: A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran European Journal of Obstetrics Gynecology and Reproductive Biology 150(1): 47-51
DelConte, A.; Loffer, F.; Grubb, G.S. 1999: Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. a multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms) and norethindrone/ethinyl estradiol (1000 micrograms/20 micrograms) Contraception 59(3): 187-193
Molina, R.C.; Sandoval, J.Z.; Montero, A.V.; Oyarzún, P.G.; Molina, T.ís.G.; González, E.A. 2009: Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents Journal of Pediatric and Adolescent Gynecology 22(1): 25-31
Carlborg, L. 1986: Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne. Results of a multicenter study Acta Obstetricia et Gynecologica Scandinavica. Suppl 134: 29-32
Lee, M.; Morgan, M.; Rapkin, A. 2011: Clitoral and vulvar vestibular sensation in women taking 20 mcg ethinyl estradiol combined oral contraceptives: a preliminary study Journal of Sexual Medicine 8(1): 213-218
Kriplani, A.; Periyasamy, A.J.; Agarwal, N.; Kulshrestha, V.; Kumar, A.; Ammini, A.C. 2010: Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome Contraception 82(2): 139-146
Suuronen, J.; Sjöblom, S.; Tuppurainen, M.; Honkanen, R.; Rikkonen, T.; Kröger, H.; Sirola, J. 2019: Effects of ethinyl estradiol-containing oral contraception and other factors on body composition and muscle strength among young healthy females in Finland-A cross-sectional study European Journal of Obstetrics Gynecology and Reproductive Biology 232: 75-81
Klipping, C.; Marr, J. 2005: Effects of two combined oral contraceptives containing ethinyl estradiol 20 μg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism Contraception (Stoneham) 71(6): 409-416
Dittrich, R.; Parker, L.; Rosen, J.B.; Shangold, G.; Creasy, G.W.; Fisher, A.C. 2002: Transdermal contraception: Evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study American Journal of Obstetrics and Gynecology 186(1): 15-20
Dittrich, R.; Parker, L.; Rosen, J.B.; Shangold, G.; Creasy, G.W.; Fisher, A.C. 2002: Transdermal contraception: Evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study American Journal of Obstetrics and Gynecology 186(1): 15-20
Creinin, M.D.; Lippman, J.S.; Eder, S.E.; Godwin, A.J.; Olson, W. 2002: The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol Contraception 66(3): 147-152
Lévrier, M. 1970: Clinical study and effect on the uterine receptor of the combination Norgestrel-Ethinyl-Estradiol (FH 122-A) in 500 menstrual cycles Bordeaux Medical 3(1): 225-226
Jensen, J.T. 2008: A continuous regimen of levonorgestrel/ethinyl estradiol for contraception and elimination of menstruation Drugs of Today 44(3): 183-195